Medical University of Vienna, Cardiology, Professor of Med., FESC, FEACVI, FHFA. @Echocardiography @CardioOncology @KardiologieWien @MedUni_Wien
Wien, Österreich
Joined December 2019
- Tweets179
- Following234
- Followers308
- Likes711
Jutta Bergler-Klein retweeted
🎙️The 1st episode of ESC CardioTalk: Cardio-Oncology is now LIVE🫀🩺
‘Which Patients Should Receive Pre-Treatment Cardiac Screening Before Chemotherapy or Immunotherapy?’
Discover expert insights and stay updated with the latest discussions🌍
👉Listen now esc365.escardio.org/event/26…
Jutta Bergler-Klein retweeted
❤️🩹 Heart failure can already be present before chemotherapy🚨or develop as a side effect of cancer treatment💊
How can we better prevent, monitor & manage cancer therapy-related cardiac dysfunction? 🩺🎗️#CardioOncology #HFA2026 @escardio
Jutta Bergler-Klein retweeted
Ahead of World Cancer Day (4 Feb) 🗓️ we’re spotlighting our Top 10 #CardioOnc articles📚—showcasing the field’s momentum, collaboration🤝🫀and the power of multidisciplinary care. Stay tuned! 🚀 doi.org/10.1093/eurheartj/eh… #ESCardioOnco26
Jutta Bergler-Klein retweeted
🌍 The ESC Council of Cardio-Oncology #CardioOnc at #HFA2026 in beautiful Barcelona🇪🇸 New projects, new research and new initiatives shaping the future 🚀
📍Want to know more? Join the Council and take part in the Vienna Congress in June 2026🇦🇹
Jutta Bergler-Klein retweeted
#HFpEF in #cancer patients is common, underdiagnosed, & prognostically important.
Read More at #HFA_ESC & #ESCCardioOnco scientific statement: 🔗 doi.org/10.1002/ejhf.70005
@escardio @ehj_ed @HFA_President @TeresaLpezFdez1 @ESC_Journals
#CardioOncology
Jutta Bergler-Klein retweeted
🩸 Cancer-associated VTE: NOAC dose matters❓In a large RCT, extended reduced-dose apixaban (2.5 mg bid) was noninferior to full dose X recurrent VTE and led to less clinically relevant bleeding ⚖️ Efficacy preserved, safety improved🫀#CardioOncology
🔗doi: 10.1056/NEJMoa2416112
Jutta Bergler-Klein retweeted
The 2nd Edition of #ESCardioOnco26 is back!🫀
Join the global #cardiooncology community in Vienna, 19–20 June 2026!📚
⏰ Key deadlines you don’t want to miss:
- 29 Jan 2026: Abstract submission
- 05 Feb 2026: Clinical case
🔗 Submit now!: escardio.org/Congresses-Even…
@escardio
Jutta Bergler-Klein retweeted
⚠️ New from #EHJ🗞️ICI-associated myocarditis is different from other myocarditis.
From a 17-country registry (n=748), a new risk score predicts severe cardiomyotoxic outcomes using troponin, thymoma, QRS voltage, LVEF & neuromuscular symptoms📊🔗doi: 10.1093/eurheartj/ehaf315.
Jutta Bergler-Klein retweeted
⚠️The #ESCardioCRT is a unique event aimed at overcoming communications’ barriers and promote dialogue in #CardioOnc🫀The @escardio is devoted to the CV Health of patients with cancer through the #COCouncil @ESCardioOnco
At the #ESCardioCRT there is unanimity in agreeing that cardio toxicity can be avoided through targeted prevention and long-term monitoring and management of cancer patients and survivors.
Teresa López Fernández shares the day’s highlights and invites you to participate in the dedicated cardio-oncology conference #ESCardioOnco26
Let’s shape together the future of this new cardiovascular specialty lnkd.in/d_WjPA77
@ESCardioOnco #cardioonco #cardioonc
Jutta Bergler-Klein retweeted
1 in 3 patients develops cardio toxicity due to oncological treatments.
Dr. Alexander Lyon summarizes discussions at #ESCardioCRT on creating a framework for improving cardiovascular safety by integrating:
⏺️ oncology pharmacotherapy
⏺️ CV pharmacotherapy
⏺️ imaging
⏺️ CV biomarkers
⏺️ digital health and data processing
⏺️ regulation of medication and trials monitoring
Listen to his insights and join us for the #ESCardioOnco26 conference, a unique environment where the full circle above will be covered escardio.org/events/councils…
#cardioonco #cardioonc
Jutta Bergler-Klein retweeted
The first #ESCardioCRT edition of the year kicked off with a programme focused on cardiovascular safety in the context of #CancerCare
ESC President-Elect Cecilia Linde shares how cardio toxicity mitigation as a result of cancer therapy must become top of mind for health professionals, healthcare industry, and regulators 👇
#patientsfirst #cardioonco #cardioonc
Jutta Bergler-Klein retweeted
Explore the latest advances in #CardioOncology with leading experts in the field🫀
The second COOL Group webinar is coming up, don’t miss it!
Join the outstanding faculty: Drs #PietroAmeri, #AlessandraGhigo, & #WouterMeijers
Register now: esc365.escardio.org/event/22…
@escardio
Jutta Bergler-Klein retweeted
🫀The ESC CRT on #CardioOncology has just successfully concluded, bringing together experts from academia, regulatory bodies, industry and patient organisations for a strategic dialogue🤝Look forward to discuss the future of #CardioOnc in Vienna #ESCardioOnco2026 Conference⚠️
Jutta Bergler-Klein retweeted
We’re thrilled to welcome you to #EACVI2025, taking place 11–13 December in Vienna — a landmark event uniting the full spectrum of cardiovascular imaging!
Echo, CMR, Nuclear, CT: all together for 3 days of cutting-edge multimodality learning.
Advancing imaging. Enhancing patient care. 🚀❤️
youtu.be/l-S4oMJ0waQ?si=Juw6…
escardio.org/Congresses-Even…
Jutta Bergler-Klein retweeted
Resérvate la fecha para #CardioTox25:
🗓 4–6 de noviembre de 2025 | 📍 Madrid
El congreso internacional de referencia en cardio-oncología vuelve con su 11.ª edición. Tres días para compartir avances, conectar disciplinas y fortalecer el cuidado CV en pacientes oncológicos.
👥 Oncólogos, hematólogos, cardiólogos, médicos de primaria, enfermería y profesionales.
Expertos nacionales e internacionales te esperan con las últimas novedades y aplicaciones clínicas reales.
🔗 Inscríbete y forma parte del futuro de la cardio-oncología.
secardiologia.es/agenda/3217…
@TeresaLpezFdez1 @DrRaulCordoba @CNIC_CARDIO @_SEOM @preventiva_SEC @clinica_sec @sehh_es @cardiooncoSEC @SEHHJoven @SEOR_ESP
Jutta Bergler-Klein retweeted
Full house in every Cardio-Oncology session in #ESCCongress 2025‼️
@escardio @TeresaLpezFdez1
#JACCOSoMe
@Massimi78530343 @slumberbell
@JACCJournals
Jutta Bergler-Klein retweeted
🫀Atrial arrhythmias are common in cancer, but cancer-specific guidance is limited. This review, from @Dr_Mike_Fradley, Robert Monsour (@PennIMResidents), & #CardioOnc Fellows Nick Wilcox & Angie Seo, outlines where we are now & where we need to go🔗tinyurl.com/2ume6u6b
Jutta Bergler-Klein retweeted
🚀 New Era of Myocardial Strain unveiled at #ASE2025!
Key takeaways: 👉 Apply strain in #HF, valvular disease, & #CardioOnc.
Incredible consensus & collaboration 👏🏼 @ASE360 @EACVIPresident @JamesDThomasMD1 @mariellesc1 @DonalErwan @lpbadano @leylaelifsade @denisamuraru @s_e_petersen @DocStrom @aniela_petrescu @benayozbay @pfelissamburu @VDelgadoGarcia
Jutta Bergler-Klein retweeted
Now💫#EuroEcho2024 📷Beethoven: Inaugural session celebrates the #EACVI & #EchoFirst 💕
🫀@denisamuraru @eromerodorta @leylaelifsade @DaniloNeglia 💫@AHagendorff @EchoSoliman @BerglerKlein @bogdan_popescu1 💫@Steph_Achenbach 💫@Sarah_Moharem @denisamuraru @JGrapsa 💫@EZancanaroMD @bernhard_gerber 💫@alessia_gimelli @EHJIMPEiC @EHJCVIEiC @ESC_Journals @escardio💫 @SHS06 @ESC_President @EACVIPresident 💫
📷 💫
Jutta Bergler-Klein retweeted
Algunos highlights de #cardiotox24. Unos dias llenos ciencia y amigos. #cardioonco @TeresaLpezFdez1 @md_arianemacedo @daniele_andres @BerglerKlein #danielacardinale @PeterMoliner
